An updated landscape on nanopharmaceutical delivery for mitigation of colon cancer
The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Abstract
Globally, colorectal cancer (CRC) continues to rank among the leading causes of cancer-related death. Systemic toxicity, multidrug resistance, and nonspecific targeting often pose challenges to conventional therapy for CRC. Because it is a complex disease with a complex genetic and environmental pathophysiology, advanced therapeutic strategies are needed. Nanotechnology presents a potential solution that may maximize therapeutic efficacy while minimizing negative effects by enabling personalized delivery of anticancer drugs. This review focuses on recent developments in colorectal drug delivery systems based on nanotechnology. Numerous nanomaterials, including liposomes, dendrimers, micelles, exosomes, and gold nanoparticles, are developed and used. Distinctive characteristics of mentioned nanocarriers are discussed along with strategies that can be employed for enhancing the delivery of drugs to colorectal cancer cells. The review also quotes the most relevant preclinical and clinical studies that show how these nanomaterials improve drug solubility, stability, and targeted delivery while overcoming the shortcomings of conventional therapies. Nanotechnology has made CRC treatment very efficient and advanced, which has opened up new possibilities for targeted drug delivery. Preclinical and clinical studies have also proved that the use of nano-formulations in colon-specific delivery systems have significant results, indicating potential for better patient outcomes. Future res…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“More recently, several nanocarriers have been created to specifically address MDR in CRC therapy by co-delivering chemotherapy drugs and ABC transporter inhibitors [109].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [109]
Citations
Cites
Colorectal cancer statistics, 2020
Siegel, R. L., Miller, K. D., Goding Sauer, A., Fedewa, S. A., Butterly, L. F., Anderson, J. C., Cercek, A., Smith, R. A., & Jemal, A. (2020) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21601 · Cited by 4,880
Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review
Biller, L. H., & Schrag, D. (2021) · JAMA · doi:10.1001/jama.2021.0106 · Cited by 2,604
Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis
de Martel, C., Georges, D., Bray, F., Ferlay, J., & Clifford, G. M. (2020) · The Lancet Global Health · doi:10.1016/s2214-109x(19)30488-7 · Cited by 2,475
Global colorectal cancer burden in 2020 and projections to 2040
Xi, Y., & Xu, P. (2021) · Translational Oncology · doi:10.1016/j.tranon.2021.101174 · Cited by 2,434
Comprehensive review of targeted therapy for colorectal cancer
Xie, Y.-H., Chen, Y.-X., & Fang, J.-Y. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0116-z · Cited by 1,687
Sawicki, T., Ruszkowska, M., Danielewicz, A., Niedźwiedzka, E., Arłukowicz, T., & Przybyłowicz, K. E. (2021) · Cancers · doi:10.3390/cancers13092025 · Cited by 921
Hossain, M. S., Karuniawati, H., Jairoun, A. A., Urbi, Z., Ooi, D. J., John, A., Lim, Y. C., Kibria, K. M. K., Mohiuddin, A. K. M., Ming, L. C., et al. (2022) · Cancers · doi:10.3390/cancers14071732 · Cited by 920 · cited 1×
“1 (Hossain et al. 2022).”
Wnt signaling in colorectal cancer: Pathogenic role and therapeutic target
Zhao, H., Ming, T., Tang, S., Ren, S., Yang, H., Liu, M., Tao, Q., & Xu, H. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01616-7 · Cited by 857
The inflammatory pathogenesis of colorectal cancer
Schmitt, M., & Greten, F. R. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-021-00534-x · Cited by 775
Treatment of Metastatic Colorectal Cancer: ASCO Guideline
Morris, V. K., Kennedy, E. B., Baxter, N. N., Benson, A. B., Cercek, A., Cho, M., Ciombor, K. K., Cremolini, C., Davis, A., Deming, D. A., et al. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.22.01690 · Cited by 682
Current trends and challenges in cancer management and therapy using designer nanomaterials
Navya, P. N., Kaphle, A., Srinivas, S. P., Bhargava, S. K., Rotello, V. M., & Daima, H. K. (2019) · Nano Convergence · doi:10.1186/s40580-019-0193-2 · Cited by 672
Metastatic colorectal cancer: mechanisms and emerging therapeutics
Shin, A. E., Giancotti, F. G., & Rustgi, A. K. (2023) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2023.01.003 · Cited by 669
M2 Macrophage-Derived Exosomes Promote Cell Migration and Invasion in Colon Cancer
Lan, J., Sun, L., Xu, F., Liu, L., Hu, F., Song, D., Hou, Z., Wu, W., Luo, X., Wang, J., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-0014 · Cited by 643
Genetic and biological hallmarks of colorectal cancer
Li, J., Ma, X., Chakravarti, D., Shalapour, S., & DePinho, R. A. (2021) · Genes & Development · doi:10.1101/gad.348226.120 · Cited by 573
Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal cancer
Kotani, D., Oki, E., Nakamura, Y., Yukami, H., Mishima, S., Bando, H., Shirasu, H., Yamazaki, K., Watanabe, J., Kotaka, M., et al. (2023) · Nature Medicine · doi:10.1038/s41591-022-02115-4 · Cited by 526
Colorectal Cancer Epidemiology: Recent Trends and Impact on Outcomes
Baidoun, F., Elshiwy, K., Elkeraie, Y., Merjaneh, Z., Khoudari, G., Sarmini, M. T., Gad, M., Al-Husseini, M., & Saad, A. (2021) · Current Drug Targets · doi:10.2174/1389450121999201117115717 · Cited by 523
Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer
Zhu, G., Pei, L., Xia, H., Tang, Q., & Bi, F. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01441-4 · Cited by 482 · cited 4×
“…the aggregation of alterations in distinct oncogenes like KRAS proto-oncogene GTPase (KRAS) and B-Raf proto-oncogene serine/threonine kinase (BRAF) (Zhu et al. 2021), as well as tumor suppressor genes including APC and tumor protein p53 (TP53), thus playing a pivotal part in the progression of CRC…”
InfluentialCardoso, R., Guo, F., Heisser, T., Hackl, M., Ihle, P., De Schutter, H., Van Damme, N., Valerianova, Z., Atanasov, T., Májek, O., et al. (2021) · The Lancet Oncology · doi:10.1016/s1470-2045(21)00199-6 · Cited by 480
Applications and Limitations of Dendrimers in Biomedicine
Chis, A. A., Dobrea, C., Morgovan, C., Arseniu, A. M., Rus, L. L., Butuca, A., Juncan, A. M., Totan, M., Vonica-Tincu, A. L., Cormos, G., et al. (2020) · Molecules · doi:10.3390/molecules25173982 · Cited by 467
Colorectal Cancer Immunotherapy: Options and Strategies
Johdi, N. A., & Sukor, N. F. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01624 · Cited by 452
Inflammation-Related Biomarkers for the Prediction of Prognosis in Colorectal Cancer Patients
Yamamoto, T., Kawada, K., & Obama, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158002 · Cited by 445
Nanocarriers for drug delivery applications
Chamundeeswari, M., Jeslin, J., & Verma, M. L. (2019) · Environmental Chemistry Letters · doi:10.1007/s10311-018-00841-1 · Cited by 444
Engineered nanomedicines with enhanced tumor penetration
Ding, J., Chen, J., Gao, L., Jiang, Z., Zhang, Y., Li, M., Xiao, Q., Lee, S. S., & Chen, X. (2019) · Nano Today · doi:10.1016/j.nantod.2019.100800 · Cited by 420
Natural product-based nanoformulations for cancer therapy: Opportunities and challenges
Kashyap, D., Tuli, H. S., Yerer, M. B., Sharma, A., Sak, K., Srivastava, S., Pandey, A., Garg, V. K., Sethi, G., & Bishayee, A. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.08.014 · Cited by 390
Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives
Edis, Z., Wang, J., Waqas, M. K., Ijaz, M., & Ijaz, M. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s289443 · Cited by 390
A Review of Polymeric Micelles and Their Applications
Perumal, S., Atchudan, R., & Lee, W. (2022) · Polymers · doi:10.3390/polym14122510 · Cited by 390
Screening and prevention of colorectal cancer
Kanth, P., & Inadomi, J. M. (2021) · BMJ · doi:10.1136/bmj.n1855 · Cited by 358
Nanoscale Drug Delivery Systems: From Medicine to Agriculture
Vega-Vásquez, P., Mosier, N. S., & Irudayaraj, J. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00079 · Cited by 323
The Role of p53 Signaling in Colorectal Cancer
Liebl, M. C., & Hofmann, T. G. (2021) · Cancers · doi:10.3390/cancers13092125 · Cited by 318
Drug delivery applications of chitin and chitosan: a review
Parhi, R. (2020) · Environmental Chemistry Letters · doi:10.1007/s10311-020-00963-5 · Cited by 307
Abedizadeh, R., Majidi, F., Khorasani, H. R., Abedi, H., & Sabour, D. (2024) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10158-3 · Cited by 293
Ajeeshkumar, K. K., Aneesh, P. A., Raju, N., Suseela, M., Ravishankar, C. N., & Benjakul, S. (2021) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12725 · Cited by 283
Dendrimers: A New Race of Pharmaceutical Nanocarriers
Mittal, P., Saharan, A., Verma, R., Altalbawy, F. M. A., Alfaidi, M. A., Batiha, G. E.-S., Akter, W., Gautam, R. K., Uddin, M. S., & Rahman, M. S. (2021) · BioMed Research International · doi:10.1155/2021/8844030 · Cited by 257
Risk Factors for the Diagnosis of Colorectal Cancer
Lewandowska, A., Rudzki, G., Lewandowski, T., Stryjkowska-Góra, A., & Rudzki, S. (2022) · Cancer Control · doi:10.1177/10732748211056692 · Cited by 254
Biomarkers in Colorectal Cancer: Current Research and Future Prospects
Ogunwobi, O. O., Mahmood, F., & Akingboye, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155311 · Cited by 250
Pathological Features and Prognostication in Colorectal Cancer
Chen, K., Collins, G., Wang, H., & Toh, J. W. T. (2021) · Current Oncology · doi:10.3390/curroncol28060447 · Cited by 242
General insight into cancer: An overview of colorectal cancer (Review)
Alzahrani, S., Al Doghaither, H., & Al‑Ghafari, A. (2021) · Molecular and Clinical Oncology · doi:10.3892/mco.2021.2433 · Cited by 219
van der Valk, M. J. M., Marijnen, C. A. M., van Etten, B., Dijkstra, E. A., Hilling, D. E., Kranenbarg, E. M.-K., Putter, H., Roodvoets, A. G. H., Bahadoer, R. R., Fokstuen, T., et al. (2020) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2020.03.011 · Cited by 213
Nanocarriers as an Emerging Platform for Cancer Therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2020) · Nano-Enabled Medical Applications · doi:10.1201/9780429399039-2 · Cited by 211
De Leo, V., Milano, F., Agostiano, A., & Catucci, L. (2021) · Polymers · doi:10.3390/polym13071027 · Cited by 208
Advanced liposome-loaded scaffolds for therapeutic and tissue engineering applications
Cheng, R., Liu, L., Xiang, Y., Lu, Y., Deng, L., Zhang, H., Santos, H. A., & Cui, W. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2019.119706 · Cited by 205
Dendrimers as efficient nanocarriers for the protection and delivery of bioactive phytochemicals
Yousefi, M., Narmani, A., & Jafari, S. M. (2020) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2020.102125 · Cited by 190
Emerging trends in colorectal cancer: Dysregulated signaling pathways (Review)
Ahmad, R., Singh, J., Wunnava, A., Al‑Obeed, O., Abdulla, M., & Srivastava, S. (2021) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2021.4847 · Cited by 189
Exosomes as potential sources of biomarkers in colorectal cancer
Xiao, Y., Zhong, J., Zhong, B., Huang, J., Jiang, L., Jiang, Y., Yuan, J., Sun, J., Dai, L., Yang, C., et al. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.01.033 · Cited by 187
Social determinants of colorectal cancer risk, stage, and survival: a systematic review
Coughlin, S. S. (2020) · International Journal of Colorectal Disease · doi:10.1007/s00384-020-03585-z · Cited by 173
Kesharwani, P., Choudhury, H., Meher, J. G., Pandey, M., & Gorain, B. (2019) · Progress in Materials Science · doi:10.1016/j.pmatsci.2019.03.003 · Cited by 170
Senthil Kumar, C., Thangam, R., Mary, S. A., Kannan, P. R., Arun, G., & Madhan, B. (2020) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2019.115682 · Cited by 168
Flavonoid Nanoparticles: A Promising Approach for Cancer Therapy
Dobrzyńska, M., Napierała, M., & Florek, E. (2020) · Biomolecules · doi:10.3390/biom10091268 · Cited by 167
Nanocarriers for targeted drug delivery
Shah, A., Aftab, S., Nisar, J., Ashiq, M. N., & Iftikhar, F. J. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102426 · Cited by 161
Drug Resistance in Colorectal Cancer: From Mechanism to Clinic
Wang, Q., Shen, X., Chen, G., & Du, J. (2022) · Cancers · doi:10.3390/cancers14122928 · Cited by 160
Colorectal Cancer: Disease Process, Current Treatment Options, and Future Perspectives
Adebayo, A. S., Agbaje, K. O., Adesina, S. K., & Olajubutu, O. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15112620 · Cited by 157
Alomrani, A., Badran, M., Harisa, G. I., ALshehry, M., Alhariri, M., Alshamsan, A., & Alkholief, M. (2019) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2019.02.008 · Cited by 143 · cited 1×
“For instance, because chitosan nanoparticles are positively charged, their ability to target negatively charged membranes can be made site-specific (Alomrani et al. 2019; Senthil Kumar et al. 2020).”
Alibolandi, M., Hoseini, F., Mohammadi, M., Ramezani, P., Einafshar, E., Taghdisi, S. M., Ramezani, M., & Abnous, K. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.07.052 · Cited by 139
Prostaglandin E2 as a potent therapeutic target for treatment of colon cancer
Karpisheh, V., Nikkhoo, A., Hojjat‐Farsangi, M., Namdar, A., Azizi, G., Ghalamfarsa, G., Sabz, G., Yousefi, M., Yousefi, B., & Jadidi‐Niaragh, F. (2019) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2019.106338 · Cited by 139
Multi drug resistance in Colorectal Cancer- approaches to overcome, advancements and future success
Ashique, S., Bhowmick, M., Pal, R., Khatoon, H., Kumar, P., Sharma, H., Garg, A., Kumar, S., & Das, U. (2024) · Advances in Cancer Biology - Metastasis · doi:10.1016/j.adcanc.2024.100114 · Cited by 139
Updates on The Use of Liposomes for Active Tumor Targeting in Cancer Therapy
Yan, W., Leung, S. S., & To, K. K. (2020) · Nanomedicine · doi:10.2217/nnm-2019-0308 · Cited by 134
Ashrafizadeh, M., Zarrabi, A., Hashemi, F., Zabolian, A., Saleki, H., Bagherian, M., Azami, N., Bejandi, A. K., Hushmandi, K., Ang, H. L., et al. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12111084 · Cited by 134
Application of Dendrimers in Anticancer Diagnostics and Therapy
Bober, Z., Bartusik‐Aebisher, D., & Aebisher, D. (2022) · Molecules · doi:10.3390/molecules27103237 · Cited by 132
Molecular mechanisms of curcumin and its analogs in colon cancer prevention and treatment
Selvam, C., Prabu, S. L., Jordan, B. C., Purushothaman, Y., Umamaheswari, A., Hosseini‐Zare, M. S., & Thilagavathi, R. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.117032 · Cited by 131
Smart nanocarriers-based drug delivery for cancer therapy: An innovative and developing strategy
Huda, S., Alam, A., & Sharma, P. K. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.102018 · Cited by 127
Zhang, M., Wang, D., Lü, F., Zhao, R., Ye, X., He, L., Ai, L., & Wu, C. (2021) · BioData Mining · doi:10.1186/s13040-020-00232-9 · Cited by 125
Aptamers in biomedicine: Selection strategies and recent advances
Ștefan, G., Hosu, O., Wael, K. D., Lobo-Castañón, M. J., & Cristea, C. (2021) · Electrochimica Acta · doi:10.1016/j.electacta.2021.137994 · Cited by 120
Challenges of Current Anticancer Treatment Approaches with Focus on Liposomal Drug Delivery Systems
Gyanani, V., Haley, J. C., & Goswami, R. (2021) · Pharmaceuticals · doi:10.3390/ph14090835 · Cited by 118
Nanotechnology in Colorectal Cancer for Precision Diagnosis and Therapy
Brar, B., Ranjan, K., Palria, A., Kumar, R., Ghosh, M., Sihag, S., & Minakshi, P. (2021) · Frontiers in Nanotechnology · doi:10.3389/fnano.2021.699266 · Cited by 115
Advancement of cancer immunotherapy using nanoparticles-based nanomedicine
Gowd, V., Ahmad, A., Tarique, M., Suhail, M., Zughaibi, T. A., Tabrez, S., & Khan, R. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.03.026 · Cited by 112
Novel strategies to reverse chemoresistance in colorectal cancer
Ma, S., Zhang, J., Yan, T., Miao, M., Cao, Y., Cao, Y., Zhang, L., & Li, L. (2023) · Cancer Medicine · doi:10.1002/cam4.5594 · Cited by 108
Driver Gene Mutations and Epigenetics in Colorectal Cancer
Raskov, H., Søby, J. H., Troelsen, J. T., Bojesen, R. D., & Gögenür, I. (2019) · Annals of Surgery · doi:10.1097/sla.0000000000003393 · Cited by 107
Ghanbari-Movahed, M., Kaceli, T., Mondal, A., Farzaei, M. H., & Bishayee, A. (2021) · Biomedicines · doi:10.3390/biomedicines9050480 · Cited by 107
Haider, M., Zaki, K. Z., El Hamshary, M. R., Hussain, Z., Orive, G., & Ibrahim, H. O. (2022) · Journal of Advanced Research · doi:10.1016/j.jare.2021.11.008 · Cited by 106
Trends in targeted delivery of nanomaterials in colon cancer diagnosis and treatment
Khan, F. A., Albalawi, R., & Pottoo, F. H. (2022) · Medicinal Research Reviews · doi:10.1002/med.21809 · Cited by 95
Guo, Y. L., Wang, M., Zou, Y., Jin, L., Zhao, Z., Liu, Q., Wang, S., & Li, J. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01586-4 · Cited by 94
Ren, R., Sun, H., Ma, C., Liu, J., & Wang, H. (2019) · Cell & Bioscience · doi:10.1186/s13578-019-0325-8 · Cited by 78
Recent advances in (chemo-)radiation therapy for rectal cancer: a comprehensive review
Roeder, F., Meldolesi, E., Gerum, S., Valentini, V., & Rödel, C. (2020) · Radiation Oncology · doi:10.1186/s13014-020-01695-0 · Cited by 77
Huang, C., Zhou, Y., Feng, X., Wang, J., Li, Y., & Yao, X. (2023) · ACS Nano · doi:10.1021/acsnano.3c00668 · Cited by 77
Adjuvant chemotherapy in resected colon cancer: When, how and how long?
Gelibter, A. J., Caponnetto, S., Urbano, F., Emiliani, A., Scagnoli, S., Sirgiovanni, G., Napoli, V. M., & Cortesi, E. (2019) · Surgical Oncology · doi:10.1016/j.suronc.2019.06.003 · Cited by 75
Immunotherapy for Colorectal Cancer: Mechanisms and Predictive Biomarkers
Carlsen, L., Huntington, K. E., & El‐Deiry, W. S. (2022) · Cancers · doi:10.3390/cancers14041028 · Cited by 74
Tolba, M. F. (2020) · International Journal of Cancer · doi:10.1002/ijc.33056 · Cited by 73
Liposome technologies towards colorectal cancer therapeutics
Sang, R., Stratton, B., Engel, A. F., & Deng, W. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.03.055 · Cited by 73
Therapeutic opportunities in colon cancer: Focus on phosphodiesterase inhibitors
Mehta, A., & Patel, B. M. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.05.043 · Cited by 72
Patil, T. S., & Deshpande, A. S. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.01.046 · Cited by 65
Ge, P., Niu, B., Wu, Y., Xu, W., Li, M., Sun, H., Zhou, H., Zhang, X.-K., & Xie, J. (2019) · Chemical Engineering Journal · doi:10.1016/j.cej.2019.123228 · Cited by 64
Targeting Colorectal Cancer Stem Cells as an Effective Treatment for Colorectal Cancer
Ma, Y., Li, W., Liu, Y., Shi, Y., Lin, Q., & Fu, D. (2020) · Technology in Cancer Research & Treatment · doi:10.1177/1533033819892261 · Cited by 64
Enhancing the landscape of colorectal cancer using targeted deep sequencing
Lee, C. S., Song, I. H., Lee, A., Kang, J., Lee, Y. S., Lee, I. K., Song, Y. S., & Lee, S. H. (2021) · Scientific Reports · doi:10.1038/s41598-021-87486-3 · Cited by 64
Chemotherapy-associated liver injury in colorectal cancer
Gangi, A., & Lu, S. C.-L. (2020) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284820924194 · Cited by 62
Pishavar, E., Ramezani, M., & Hashemi, M. (2019) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2019.1680995 · Cited by 61
Chen, L., Yang, F., Chen, S., & Tai, J. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.995882 · Cited by 60
Nanoparticles in Colorectal Cancer Therapy: Latest In Vivo Assays, Clinical Trials, and Patents
Cabeza, L., Perazzoli, G., Mesas, C., Jiménez-Luna, C., Prados, J., Rama, A. R., & Melguizo, C. (2020) · AAPS PharmSciTech · doi:10.1208/s12249-020-01731-y · Cited by 58
Theranostics Nanomedicine Applications for Colorectal Cancer and Metastasis: Recent Advances
Kasi, P. B., Mallela, V. R., Ambrożkiewicz, F., Trailin, A. V., Liška, V., & Hemminki, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097922 · Cited by 57
Zhao, P., Yin, W., Wu, A., Tang, Y., Wang, J., Pan, Z., Lin, T., Zhang, M., Chen, B., Duan, Y., et al. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201910144 · Cited by 55
Langridge, T. D., & Gemeinhart, R. A. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.12.038 · Cited by 51
CD133: An emerging prognostic factor and therapeutic target in colorectal cancer
Akbari, M., Shomali, N., Faraji, A., Shanehbandi, D., Asadi, M., Mokhtarzadeh, A., Shabani, A., & Baradaran, B. (2020) · Cell Biology International · doi:10.1002/cbin.11243 · Cited by 49
State-of-the-Art Management of Colorectal Cancer: Treatment Advances and Innovation
Pathak, P., Chan, G. H. J., Deming, D. A., & Chee, C. E. (2024) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_438466 · Cited by 49
Recent cancer incidence trends in Ukraine and short-term predictions to 2022
Ryzhov, A., Bray, F., Ferlay, J., Zp, F., Goulak, L., Gorokh, Y., Sumkina, O. V., Michailovich, Y., & Znaor, A. (2019) · Cancer Epidemiology · doi:10.1016/j.canep.2019.101663 · Cited by 48
England, R., Moss, J. I., Gunnarsson, A., Parker, J. S., & Ashford, M. B. (2020) · Biomacromolecules · doi:10.1021/acs.biomac.0c00768 · Cited by 47
Wang, M., Su, Z., & Barnie, P. A. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106298 · Cited by 46
Hani, U., Kumar, H. Y., Begum, M. Y., Yasmin, S., Osmani, R. A. M., & Ansari, M. Y. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102532 · Cited by 42
Advani, S., Swartz, M. D., Loree, J. M., Davis, J. S., Sarsashek, A. M., Lam, M. S., Lee, M. S., Bressler, J., López, D. S., Daniel, C. R., et al. (2020) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2020.09.007 · Cited by 41
Roles of exosomes in diagnosis and treatment of colorectal cancer
Umwali, Y., Yue, C.-B., Gabriel, A. N. A., Zhang, Y., & Zhang, X. (2021) · World Journal of Clinical Cases · doi:10.12998/wjcc.v9.i18.4467 · Cited by 41
Nanoparticles: The future of effective diagnosis and treatment of colorectal cancer?
Naeimi, R., Najafi, R., Molaei, P., Amini, R., & Pecic, S. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175350 · Cited by 40
Albadari, N. G., Xie, Y., & Li, W. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1340401 · Cited by 37
Bender, U., Rho, Y. S., Barrera, I., Aghajanyan, S., Acoba, J., & Kavan, P. (2019) · Current Oncology · doi:10.3747/co.26.5605 · Cited by 36
Franco, M. S., & Oliveira, M. C. (2018) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520618666180420170124 · Cited by 34
Tapial, S., López, S. O., Rueda, D., Arriba, M., García, J. L., López, A. V., Pérez, J., Pena-Couso, L., Olivera-Salazar, R., Rodríguez, Y., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-47014-w · Cited by 34
In silico and in vitro design of cordycepin encapsulation in liposomes for colon cancer treatment
Khuntawee, W., Amornloetwattana, R., Vongsangnak, W., Namdee, K., Yata, T., Karttunen, M., & Wong-ekkabut, J. (2021) · RSC Advances · doi:10.1039/d1ra00038a · Cited by 34
Recent Development and Future Aspects: Nano-Based Drug Delivery System in Cancer Therapy
Rajendran, S., Ravi, S. N., Nair, V. M., Sree, R. P., Packirisamy, A. S. B., & Palanivelu, J. (2024) · Topics in Catalysis · doi:10.1007/s11244-023-01893-6 · Cited by 32
Nano pharmaceutical delivery in combating colorectal cancer
Singh, S. K., Solanki, R., & Patel, S. (2023) · Medicine in Drug Discovery · doi:10.1016/j.medidd.2023.100173 · Cited by 31
Ahmadi, M., Jafari, R., Mahmoodi, M., & Rezaie, J. (2021) · Cell Biochemistry and Function · doi:10.1002/cbf.3622 · Cited by 30
Micelles in Cancer Therapy: An Update on Preclinical and Clinical Status
Kushwaha, P., Aqeel, R., & Srivastava, N. (2021) · Recent Patents on Nanotechnology · doi:10.2174/1872210515666210720125717 · Cited by 30
Yue, Z., Zhu, Y., Chen, T., Feng, T., Zhou, Y. P., Zhang, J., Zhang, N., Yang, J., Luo, G., & Wang, Z. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1380229 · Cited by 30
Triumph against cancer: invading colorectal cancer with nanotechnology
Vinchhi, P., & Patel, M. M. (2021) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2021.1889512 · Cited by 28
Colorectal cancer therapy mediated by nanomedicines
Zhang, S., Zhang, H., Song, P., Wang, D., & Wang, Y. (2023) · Chemical Communications · doi:10.1039/d2cc06212g · Cited by 27
Yang, J. P., Tao, R. X., Wang, L., Song, L., Wang, Y., Gong, C., Yao, S., & Wu, Q. (2019) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2019.2734 · Cited by 25
Orally delivered targeted nanotherapeutics for the treatment of colorectal cancer
Zhang, X., Song, H., Canup, B. S. B., & Xiao, B. (2020) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2020.1748005 · Cited by 25
Chawla, M., Kaushik, R. D., Singh, J., & Manila (2020) · Scientific Reports · doi:10.1038/s41598-020-77540-x · Cited by 25
Exosomal circRNAs: new players in colorectal cancer
Vakhshiteh, F., Hassani, S., Momenifar, N., & Pakdaman, F. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02112-6 · Cited by 24
Association of Quality and Technology With Patient Mobility for Colorectal Cancer Surgery
Aggarwal, A. K., Han, L., Boyle, J. M., Lewis, D. J., Kuyruba, A., Braun, M., Walker, K., Fearnhead, N. S., Sullivan, R. J., & van der Meulen, J. (2022) · JAMA Surgery · doi:10.1001/jamasurg.2022.5461 · Cited by 21
Dual Role of Vitamin C-Encapsulated Liposomal Berberine in Effective Colon Anticancer Immunotherapy
Mianowska, M., Zaremba-Czogalla, M., Zygmunt, A., Mahmud, M., Süss, R., & Gubernator, J. (2023) · Pharmaceuticals · doi:10.3390/ph17010005 · Cited by 18
Nanomedicine-based multimodal therapies: Recent progress and perspectives in colon cancer
He, Y., Hao, Z.-N., Li, Z., & Gao, D. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i4.670 · Cited by 17
Handbook of Oncobiology: From Basic to Clinical Sciences
Sobti, R. C., Ganguly, N. K., & Kumar, R. (2023) · Springer eBooks · doi:10.1007/978-981-99-2196-6 · Cited by 17
Liposomal Drug Delivery: Progress, Clinical Outlook, and Ongoing Challenges
Tiwari, C., Tomer, J., & Kumar, D. (2024) · Recent Advances in Drug Delivery and Formulation · doi:10.2174/0126673878300031240703070511 · Cited by 15
Gajjar, S., & Patel, B. M. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173805 · Cited by 11
Liposomic nano particles in the treatment of colorectal and ovarian cancer
Ali, S. R., Deori, C., Gogoi, G. K., Borah, N. J., Kalita, P. P., Chowdhury, R., Kaur, S., & Kakoti, B. B. (2024) · European Journal of Medicinal Chemistry Reports · doi:10.1016/j.ejmcr.2024.100149 · Cited by 10
Varshosaz, J., Fardshouraki, S., Mirian, M., Safaeian, L., Jandaghian, S., & Taymouri, S. (2020) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520620666200619174323 · Cited by 9
Flatin, B. T. B., Vedeld, H. M., Pinto, R., Langerud, J., Lind, G. E., Lothe, R. A., Sveen, A., & Jeanmougin, M. (2020) · International Journal of Cancer · doi:10.1002/ijc.33425 · Cited by 7
Chitosan in colon-targeted drug delivery
Padhi, S., Behera, A., Hasnain, M. S., & Nayak, A. K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819336-5.00019-4 · Cited by 7
Recent Advances in Colon Drug Delivery Technology
Pahwa, R., Bajaj, R., Bhateja, P., & Piplani, M. (2021) · Drug Delivery Letters · doi:10.2174/2210303111666210129143612 · Cited by 1
Cited by
Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer
Haynes, J., & Manogaran, P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26051988 · Cited by 82
Smeu, A., Marcovici, I., Dehelean, C. A., Dumitrel, Ș.-I., Borza, C., & Lighezan, R. (2025) · Pharmaceuticals · doi:10.3390/ph18020231 · Cited by 29
Advances in nanotechnology for colorectal cancer: a smart targeting and theranostics approach
Sahoo, S. P., Samal, S., Sahu, R., & Acharya, B. (2025) · Medical Oncology · doi:10.1007/s12032-025-02910-2 · Cited by 14
Organic nanoplatforms for metallodrugs delivery: Current advances in colorectal cancer
Neto, Í., Rocha, J. P., Gaspar, M. M., & Reis, C. P. (2026) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2026.189547 · Cited by 7
Boufissiou, A., Abdalla, M., Kadi, I., Hachani, S., Eltayb, W. A., Awadalla, M., Algarni, A. S., Benarfa, A., Bouchareb, A., Benaceur, F., et al. (2025) · Network Modeling Analysis in Health Informatics and Bioinformatics · doi:10.1007/s13721-025-00543-z · Cited by 5
Metadata
- Authors
- Shahzad, M., Hameed, H., Amjad, A., Khan, M. A., Qureshi, I. S., Hameed, A., Saeed, A., & Munir, R.
- Affiliations
- University of Central Punjab (PK)
- Lahore University of Biological and Applied Sciences (PK)
- Riphah International University (PK)
- Government College University, Faisalabad (PK)
- Corresponding author
- Hameed, Huma
- Venue
- Naunyn-Schmiedeberg's Archives of Pharmacology
- Published
- 2024-10-03
- Volume
- 398
- Issue
- 3
- Pages
- 2107-2125
- ISSN
- 0028-1298 (ISSN-L)
- 1432-1912
- OpenAlex
- W4403106438
- Cited by
- 7
- References
- 126
- Citations by year
- 2026: 4 · 2025: 3
- FWCI
- 0.20
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Naunyn-Schmiedeberg s Archives of Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Pharmacology and Nanomedicine Research
- Keywords
- colorectal cancer, colon cancer, targeted drug delivery, nanocarriers, liposomes, dendrimers, micelles, exosomes, gold nanoparticles, multidrug resistance, colon-targeted drug delivery, drug solubility and stability, biocompatibility, nanomedicine regulation
- MeSH terms
- Nanoparticle Drug Delivery System, Animals, Antineoplastic Agents, Colonic Neoplasms, Drug Carriers, Humans, Drug Delivery Systems, Nanotechnology
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.